Corbus Pharmaceuticals (CRBP) PT Lowered to $53 at Oppenheimer

August 6, 2025 7:57 AM EDT Send to a Friend

Oppenheimer analyst Jeff Jones lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Corbus Pharmaceuticals (CRBP) PT Lowered to $53 at Oppenheimer

Member Login

Free News Feed